A
$177.49+0.87%
as of close, Oct 27, 2026
☾ AH $177.49 +0.87%
A — Agilent Technologies Inc. price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeDDDDDDDDDDDDDDDDDDDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDEDED
60.080.0100.0120.0140.0160.0020.0M$177.49—20162019202120242026
2026-10-27
Price$177.49
MA20$146.81
MA50$137.50
Vol8.4M
Key stats#
Price data
- Price
- $177.49
- YTD price return
- +30.44%
- YTD total return
- +31.42%
- Next earnings
- Nov 23, 2026
- Market cap
- 50B
- Enterprise value
- 52.4B
- Shares outstanding
- 281.9M
- 52W low
- $108.35
- 52W high
- $179.10
- From 52W high
- -0.90%
- From 52W low
- +63.81%
- 52W range
- 98%
- Beta
- 1.23
Volume
- Rel volume
- 0.94×
- 30D volume
- 2.4M
- 30D $ vol
- 412.4M
Insider trading
- Insider net 1W
- none
- Insider net 1M
- none
- Insider net 3M
- −$96K
- Insider net 1Y
- −$313K
Form 4 transactions by trade date, as filed; latest on file 2026-09-04.
Fundamentals
- Sales (ttm)
- 7.4B
- Sales/share
- $26.15
- EPS (ttm)
- $5.07
- FCF (ttm)
- 1.3B
- FCF/share
- $4.49
- Book value/share
- $26.12
- Net margin
- 19.53%
- ROE
- 19.56%
- ROA
- 10.31%
- Debt / equity
- 0.50×
- Current ratio
- 2.05
Growth (CAGR, ttm) · 10Y
- Sales
- +8.61%+1.77%+3.72%+5.98%
- Net income
- +18.05%+8.32%+7.78%+11.71%
- FCF
- +16.46%-3.73%-0.02%+6.33%
- Shares
- -0.55%-1.23%-1.41%-1.39%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +18.77%+9.92%+9.60%+13.41%
- Sales/share
- +9.22%+3.04%+5.21%+7.47%
- FCF/share
- +17.11%-2.53%+1.42%+7.83%
- Book value/share
- +16.25%+11.19%+9.84%+6.91%
- Dividend/share
- +3.37%+4.60%+5.86%+8.57%
- Price
- +21.10%+19.97%+2.71%+15.13%
- Total return
- +22.00%+20.87%+3.45%+16.03%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 35.0×
- P/OI (ttm)
- 30.5×
- Fwd P/E
- 25.7×
- P/S (ttm)
- 6.8×
- P/B (mrq)
- 6.8×
- P/FCF (ttm)
- 39.5×
- EV/EBITDA (fy)
- 27.5×
- EV/Sales (ttm)
- 7.1×
- FCF yield (ttm)
- 2.53%
- Dividend yield (fwd)
- 0.57%
- Dividend yield (ttm)
- 0.57%
- Dividend/share (fwd)
- $1.02
- Buyback yield (realized, 1y)
- 0.55%
- Shareholder yield (realized, 1y)
- 1.43%
- Buyback yield (cash, ttm)
- 0.76%
- Shareholder yield (cash, ttm)
- 1.33%
Vs own 10Y history
- P/E
- 73rd
- P/OI
- 80th
- P/S
- 90th
- P/B
- 71st
- P/FCF
- 87th
Bar = where today’s multiple sits in A’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-27#
1D
+0.87%
5D
+2.59%
1M
+2.72%
3M
+28.72%
YTD
+30.44%
1Y
+21.08%
5Y
+14.32%
Recent filings#
- Sep 88-K · Agilent Announces Retirement of Board Chair Koh Boon Hwee, Appointment of Glenn Boehnlein to Board of Directors
- Sep 4Insider sale · Dolsten Mikael (Director) sold 634 shares for $96K at $151.38
- Aug 26Earnings · Earnings release — EPS $1.62 vs $1.48 est. (+9.5%); revenue $1.88B (+8% y/y) 1.7%
Financial statements
Open full A financials →Loading financial statements…
Related Healthcare#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +8.32% | +0.22% |
| JNJ | Johnson & Johnson | -0.92% | +0.91% |
| ABBV | AbbVie Inc. | +8.34% | -0.12% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +8.98% | -0.08% |
| MRK | Merck & Co. Inc. | -4.68% | +0.86% |
| NVS | Novartis AG | +7.84% | +1.98% |
| TMO | Thermo Fisher Scientific Inc. | +2.67% | +1.19% |
| AMGN | Amgen Inc. | +8.04% | +0.75% |
